The growing prevalence of gastrointestinal and other chronic disorders is increasing the need for precise diagnostic and therapeutic procedures. Advances in minimally invasive technologies are also improving procedural safety, efficiency, and patient recovery.
The Endotherapy Devices Market was valued at US$4.42 billion in 2024 and is projected to reach US$6.78 billion by 2031, expanding at a CAGR of 6.3% during 2025 to 2031. Increasing gastrointestinal disorders, technological advancements, and the rising adoption of outpatient procedures are among the major factors supporting this growth.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00004737
Rising Prevalence of Gastrointestinal Disorders Drives Demand
The increasing incidence of gastrointestinal disorders, including inflammatory bowel disease, colorectal cancer, and other digestive system conditions, is creating sustained demand for endoscopic diagnosis and intervention. Endotherapy devices allow healthcare professionals to perform therapeutic procedures through minimally invasive approaches, reducing the need for conventional open surgery in suitable cases.
The growing aging population and increasing awareness of early disease detection are further contributing to procedure volumes. As healthcare providers focus on improving clinical outcomes while reducing hospitalization periods, endoscopic approaches are becoming increasingly important across gastrointestinal and related specialties.
Technological Advancements Strengthen Product Adoption
Technological innovation remains a major growth contributor. High-definition visualization, advanced imaging, improved endoscopic accessories, and robotic-assisted technologies are enhancing the precision and safety of endotherapy procedures. These developments enable clinicians to identify abnormalities more accurately and perform targeted interventions.
Image-guided endotherapy is gaining attention because real-time visualization can improve lesion identification and procedural accuracy. Manufacturers are also focusing on ergonomic device designs, improved maneuverability, and advanced materials that support more efficient procedures. These innovations are expected to broaden the use of endotherapy devices across hospitals and specialized clinics.
Product and Application Landscape
Based on product, the industry is segmented into gastrointestinal devices and accessories, endoscopic retrograde cholangio pancreatography devices and accessories, and others. Gastrointestinal devices and accessories represent an important segment due to the extensive use of endoscopic procedures for diagnosis and treatment of digestive disorders.
By application, the segments include bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuroendoscopy, gastrointestinal endoscopy, and other applications. Gastrointestinal endoscopy is expected to remain a significant area of utilization due to the increasing prevalence of gastrointestinal diseases and growing emphasis on minimally invasive treatment.
Hospitals represent a major end-user segment because of their extensive procedural infrastructure and availability of specialized healthcare professionals. However, clinics and outpatient facilities are also increasingly adopting endotherapy solutions as healthcare systems shift toward shorter-stay and ambulatory procedures.
Regional Growth and Competitive Landscape
North America represents a key regional market, supported by advanced healthcare infrastructure, high adoption of minimally invasive technologies, and increasing gastrointestinal disease burden. Europe is also characterized by established healthcare systems and continued investments in medical technology. Meanwhile, Asia-Pacific offers significant growth opportunities because of improving healthcare infrastructure, increasing healthcare expenditure, and growing awareness of advanced treatment options.
Emerging economies in Asia-Pacific, South and Central America, and the Middle East and Africa are expected to provide manufacturers with opportunities to expand their presence through localized products, partnerships, and healthcare system collaborations.
Key players include:
- Stryker Corporation
- Medtronic Plc.
- Olympus Corporation
- HOYA Corporation
- FUJIFILM Holdings Corporation
- CONMED Corporation
- Boston Scientific Corporation
- Smith & Nephew Plc.
- KARL STORZ GmbH & Co KG
- Johnson & Johnson
These companies are focusing on product development, technological innovation, strategic collaborations, and geographic expansion to strengthen their competitive positions.
Future Outlook
The Endotherapy Devices Market is expected to maintain steady growth through 2031 as healthcare providers increasingly prioritize minimally invasive interventions, improved patient outcomes, and shorter recovery periods. The adoption of disposable instruments is also gaining momentum because of infection-control requirements and efforts to reduce cross-contamination risks. In parallel, collaboration between medical device manufacturers and digital health companies could support remote monitoring, connected procedures, and improved post-procedure care.
Related Report:
1) Preservative-Free Eye Drops Market Size & Trends 2031
2) Viral Vector Manufacturing Market Insights & Growth Scope by 2031
3) Fluorine-18 Market Size, Trends & Forecast 2031
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish